Covid-19 Impact on Global Cancer Screening Technology Market Size, Status and Forecast 2020-2026

July 2020 | 127 pages | ID: CA4D4C6AE2A5EN
QYResearch

Abstracts

Cancer Screening Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Screening Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cancer Screening Technology market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Cancer Screening Technology industry.
The key players covered in this study

• Abbott
• BD
• Siemens Healthineers
• GE Healthcare
• F. Hoffmann-La Roche
• Olympus Corporation
• FUJIFILM Corporation
• Agilent Technologies
• Eiken Chemical
• Hitachi Chemical (Kyowa Medex)
• Clinical Genomics Pty Ltd (Quest Diagnostics)
• Sysmex
• QIAGEN
• R-Biopharm
• Immunostics

Market segment by Type, the product can be split into

• Instrument-based Inspection
• Platform-based Inspection

Market segment by Application, split into

• Lung Cancer Screening
• Breast Cancer Screening
• Prostate Cancer Screening
• Colorectal Cancer Screening
• Blood Cancer Screening
• Liver Cancer Screening
• Pancreatic Cancer Screening
• Skin Cancer Screening
• Cervical Cancer Screening

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cancer Screening Technology status, future forecast, growth opportunity, key market and key players.
• To present the Cancer Screening Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Screening Technology are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Screening Technology Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Instrument-based Inspection
  1.4.3 Platform-based Inspection
1.5 Market by Application
  1.5.1 Global Cancer Screening Technology Market Share by Application: 2020 VS 2026
  1.5.2 Lung Cancer Screening
  1.5.3 Breast Cancer Screening
  1.5.4 Prostate Cancer Screening
  1.5.5 Colorectal Cancer Screening
  1.5.6 Blood Cancer Screening
  1.5.7 Liver Cancer Screening
  1.5.8 Pancreatic Cancer Screening
  1.5.9 Skin Cancer Screening
  1.5.10 Cervical Cancer Screening
  1.5.11 Other
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Screening Technology Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Cancer Screening Technology Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Cancer Screening Technology Growth Trends by Regions
  2.2.1 Cancer Screening Technology Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cancer Screening Technology Historic Market Share by Regions (2015-2020)
  2.2.3 Cancer Screening Technology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cancer Screening Technology Market Growth Strategy
  2.3.6 Primary Interviews with Key Cancer Screening Technology Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cancer Screening Technology Players by Market Size
  3.1.1 Global Top Cancer Screening Technology Players by Revenue (2015-2020)
  3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Screening Technology Market Concentration Ratio
  3.2.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2019
3.3 Cancer Screening Technology Key Players Head office and Area Served
3.4 Key Players Cancer Screening Technology Product Solution and Service
3.5 Date of Enter into Cancer Screening Technology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Cancer Screening Technology Historic Market Size by Type (2015-2020)
4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Cancer Screening Technology Market Size by Application (2015-2020)
5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Cancer Screening Technology Market Size (2015-2020)
6.2 Cancer Screening Technology Key Players in North America (2019-2020)
6.3 North America Cancer Screening Technology Market Size by Type (2015-2020)
6.4 North America Cancer Screening Technology Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Cancer Screening Technology Market Size (2015-2020)
7.2 Cancer Screening Technology Key Players in Europe (2019-2020)
7.3 Europe Cancer Screening Technology Market Size by Type (2015-2020)
7.4 Europe Cancer Screening Technology Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Cancer Screening Technology Market Size (2015-2020)
8.2 Cancer Screening Technology Key Players in China (2019-2020)
8.3 China Cancer Screening Technology Market Size by Type (2015-2020)
8.4 China Cancer Screening Technology Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Cancer Screening Technology Market Size (2015-2020)
9.2 Cancer Screening Technology Key Players in Japan (2019-2020)
9.3 Japan Cancer Screening Technology Market Size by Type (2015-2020)
9.4 Japan Cancer Screening Technology Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Cancer Screening Technology Market Size (2015-2020)
10.2 Cancer Screening Technology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Screening Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Screening Technology Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Cancer Screening Technology Market Size (2015-2020)
11.2 Cancer Screening Technology Key Players in India (2019-2020)
11.3 India Cancer Screening Technology Market Size by Type (2015-2020)
11.4 India Cancer Screening Technology Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Cancer Screening Technology Market Size (2015-2020)
12.2 Cancer Screening Technology Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Screening Technology Market Size by Type (2015-2020)
12.4 Central & South America Cancer Screening Technology Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Cancer Screening Technology Introduction
  13.1.4 Abbott Revenue in Cancer Screening Technology Business (2015-2020))
  13.1.5 Abbott Recent Development and Reaction to COVID-19
13.2 BD
  13.2.1 BD Company Details
  13.2.2 BD Business Overview and Its Total Revenue
  13.2.3 BD Cancer Screening Technology Introduction
  13.2.4 BD Revenue in Cancer Screening Technology Business (2015-2020)
  13.2.5 BD Recent Development and Reaction to COVID-19
13.3 Siemens Healthineers
  13.3.1 Siemens Healthineers Company Details
  13.3.2 Siemens Healthineers Business Overview and Its Total Revenue
  13.3.3 Siemens Healthineers Cancer Screening Technology Introduction
  13.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2015-2020)
  13.3.5 Siemens Healthineers Recent Development and Reaction to COVID-19
13.4 GE Healthcare
  13.4.1 GE Healthcare Company Details
  13.4.2 GE Healthcare Business Overview and Its Total Revenue
  13.4.3 GE Healthcare Cancer Screening Technology Introduction
  13.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2015-2020)
  13.4.5 GE Healthcare Recent Development and Reaction to COVID-19
13.5 F. Hoffmann-La Roche
  13.5.1 F. Hoffmann-La Roche Company Details
  13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
  13.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2015-2020)
  13.5.5 F. Hoffmann-La Roche Recent Development and Reaction to COVID-19
13.6 Olympus Corporation
  13.6.1 Olympus Corporation Company Details
  13.6.2 Olympus Corporation Business Overview and Its Total Revenue
  13.6.3 Olympus Corporation Cancer Screening Technology Introduction
  13.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2015-2020)
  13.6.5 Olympus Corporation Recent Development and Reaction to COVID-19
13.7 FUJIFILM Corporation
  13.7.1 FUJIFILM Corporation Company Details
  13.7.2 FUJIFILM Corporation Business Overview and Its Total Revenue
  13.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
  13.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2015-2020)
  13.7.5 FUJIFILM Corporation Recent Development and Reaction to COVID-19
13.8 Agilent Technologies
  13.8.1 Agilent Technologies Company Details
  13.8.2 Agilent Technologies Business Overview and Its Total Revenue
  13.8.3 Agilent Technologies Cancer Screening Technology Introduction
  13.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2015-2020)
  13.8.5 Agilent Technologies Recent Development and Reaction to COVID-19
13.9 Eiken Chemical
  13.9.1 Eiken Chemical Company Details
  13.9.2 Eiken Chemical Business Overview and Its Total Revenue
  13.9.3 Eiken Chemical Cancer Screening Technology Introduction
  13.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2015-2020)
  13.9.5 Eiken Chemical Recent Development and Reaction to COVID-19
13.10 Hitachi Chemical (Kyowa Medex)
  13.10.1 Hitachi Chemical (Kyowa Medex) Company Details
  13.10.2 Hitachi Chemical (Kyowa Medex) Business Overview and Its Total Revenue
  13.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
  13.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2015-2020)
  13.10.5 Hitachi Chemical (Kyowa Medex) Recent Development and Reaction to COVID-19
13.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
  10.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
  10.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview and Its Total Revenue
  10.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
  10.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2015-2020)
  10.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development and Reaction to COVID-19
13.12 Sysmex
  10.12.1 Sysmex Company Details
  10.12.2 Sysmex Business Overview and Its Total Revenue
  10.12.3 Sysmex Cancer Screening Technology Introduction
  10.12.4 Sysmex Revenue in Cancer Screening Technology Business (2015-2020)
  10.12.5 Sysmex Recent Development and Reaction to COVID-19
13.13 QIAGEN
  10.13.1 QIAGEN Company Details
  10.13.2 QIAGEN Business Overview and Its Total Revenue
  10.13.3 QIAGEN Cancer Screening Technology Introduction
  10.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2015-2020)
  10.13.5 QIAGEN Recent Development and Reaction to COVID-19
13.14 R-Biopharm
  10.14.1 R-Biopharm Company Details
  10.14.2 R-Biopharm Business Overview and Its Total Revenue
  10.14.3 R-Biopharm Cancer Screening Technology Introduction
  10.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2015-2020)
  10.14.5 R-Biopharm Recent Development and Reaction to COVID-19
13.15 Immunostics
  10.15.1 Immunostics Company Details
  10.15.2 Immunostics Business Overview and Its Total Revenue
  10.15.3 Immunostics Cancer Screening Technology Introduction
  10.15.4 Immunostics Revenue in Cancer Screening Technology Business (2015-2020)
  10.15.5 Immunostics Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cancer Screening Technology Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Screening Technology Revenue
Table 3. Ranking of Global Top Cancer Screening Technology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Screening Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instrument-based Inspection
Table 6. Key Players of Platform-based Inspection
Table 7. COVID-19 Impact Global Market: (Four Cancer Screening Technology Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Cancer Screening Technology Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Cancer Screening Technology Players to Combat Covid-19 Impact
Table 12. Global Cancer Screening Technology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Cancer Screening Technology Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Cancer Screening Technology Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Cancer Screening Technology Market Share by Regions (2015-2020)
Table 16. Global Cancer Screening Technology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Cancer Screening Technology Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Cancer Screening Technology Market Growth Strategy
Table 22. Main Points Interviewed from Key Cancer Screening Technology Players
Table 23. Global Cancer Screening Technology Revenue by Players (2015-2020) (Million US$)
Table 24. Global Cancer Screening Technology Market Share by Players (2015-2020)
Table 25. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Technology as of 2019)
Table 26. Global Cancer Screening Technology by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cancer Screening Technology Product Solution and Service
Table 29. Date of Enter into Cancer Screening Technology Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 32. Global Cancer Screening Technology Market Size Share by Type (2015-2020)
Table 33. Global Cancer Screening Technology Revenue Market Share by Type (2021-2026)
Table 34. Global Cancer Screening Technology Market Size Share by Application (2015-2020)
Table 35. Global Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 36. Global Cancer Screening Technology Market Size Share by Application (2021-2026)
Table 37. North America Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Cancer Screening Technology Market Share (2019-2020)
Table 39. North America Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 40. North America Cancer Screening Technology Market Share by Type (2015-2020)
Table 41. North America Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 42. North America Cancer Screening Technology Market Share by Application (2015-2020)
Table 43. Europe Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Cancer Screening Technology Market Share (2019-2020)
Table 45. Europe Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Cancer Screening Technology Market Share by Type (2015-2020)
Table 47. Europe Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Cancer Screening Technology Market Share by Application (2015-2020)
Table 49. China Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 50. China Key Players Cancer Screening Technology Market Share (2019-2020)
Table 51. China Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 52. China Cancer Screening Technology Market Share by Type (2015-2020)
Table 53. China Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 54. China Cancer Screening Technology Market Share by Application (2015-2020)
Table 55. Japan Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Cancer Screening Technology Market Share (2019-2020)
Table 57. Japan Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Cancer Screening Technology Market Share by Type (2015-2020)
Table 59. Japan Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Cancer Screening Technology Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Cancer Screening Technology Market Share (2019-2020)
Table 63. Southeast Asia Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Cancer Screening Technology Market Share by Type (2015-2020)
Table 65. Southeast Asia Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Cancer Screening Technology Market Share by Application (2015-2020)
Table 67. India Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 68. India Key Players Cancer Screening Technology Market Share (2019-2020)
Table 69. India Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 70. India Cancer Screening Technology Market Share by Type (2015-2020)
Table 71. India Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 72. India Cancer Screening Technology Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Cancer Screening Technology Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Cancer Screening Technology Market Share (2019-2020)
Table 75. Central & South America Cancer Screening Technology Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Cancer Screening Technology Market Share by Type (2015-2020)
Table 77. Central & South America Cancer Screening Technology Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Cancer Screening Technology Market Share by Application (2015-2020)
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD Product
Table 87. BD Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 88. BD Recent Development
Table 89. Siemens Healthineers Company Details
Table 90. Siemens Healthineers Business Overview
Table 91. Siemens Healthineers Product
Table 92. Siemens Healthineers Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 93. Siemens Healthineers Recent Development
Table 94. GE Healthcare Company Details
Table 95. GE Healthcare Business Overview
Table 96. GE Healthcare Product
Table 97. GE Healthcare Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 98. GE Healthcare Recent Development
Table 99. F. Hoffmann-La Roche Company Details
Table 100. F. Hoffmann-La Roche Business Overview
Table 101. F. Hoffmann-La Roche Product
Table 102. F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 103. F. Hoffmann-La Roche Recent Development
Table 104. Olympus Corporation Company Details
Table 105. Olympus Corporation Business Overview
Table 106. Olympus Corporation Product
Table 107. Olympus Corporation Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 108. Olympus Corporation Recent Development
Table 109. FUJIFILM Corporation Company Details
Table 110. FUJIFILM Corporation Business Overview
Table 111. FUJIFILM Corporation Product
Table 112. FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 113. FUJIFILM Corporation Recent Development
Table 114. Agilent Technologies Business Overview
Table 115. Agilent Technologies Product
Table 116. Agilent Technologies Company Details
Table 117. Agilent Technologies Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 118. Agilent Technologies Recent Development
Table 119. Eiken Chemical Company Details
Table 120. Eiken Chemical Business Overview
Table 121. Eiken Chemical Product
Table 122. Eiken Chemical Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 123. Eiken Chemical Recent Development
Table 124. Hitachi Chemical (Kyowa Medex) Company Details
Table 125. Hitachi Chemical (Kyowa Medex) Business Overview
Table 126. Hitachi Chemical (Kyowa Medex) Product
Table 127. Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 128. Hitachi Chemical (Kyowa Medex) Recent Development
Table 129. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 130. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 131. Clinical Genomics Pty Ltd (Quest Diagnostics) Product
Table 132. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 133. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
Table 134. Sysmex Company Details
Table 135. Sysmex Business Overview
Table 136. Sysmex Product
Table 137. Sysmex Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 138. Sysmex Recent Development
Table 139. QIAGEN Company Details
Table 140. QIAGEN Business Overview
Table 141. QIAGEN Product
Table 142. QIAGEN Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 143. QIAGEN Recent Development
Table 144. R-Biopharm Company Details
Table 145. R-Biopharm Business Overview
Table 146. R-Biopharm Product
Table 147. R-Biopharm Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 148. R-Biopharm Recent Development
Table 149. Immunostics Company Details
Table 150. Immunostics Business Overview
Table 151. Immunostics Product
Table 152. Immunostics Revenue in Cancer Screening Technology Business (2015-2020) (Million US$)
Table 153. Immunostics Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cancer Screening Technology Market Share by Type: 2020 VS 2026
Figure 2. Instrument-based Inspection Features
Figure 3. Platform-based Inspection Features
Figure 4. Global Cancer Screening Technology Market Share by Application: 2020 VS 2026
Figure 5. Lung Cancer Screening Case Studies
Figure 6. Breast Cancer Screening Case Studies
Figure 7. Prostate Cancer Screening Case Studies
Figure 8. Colorectal Cancer Screening Case Studies
Figure 9. Blood Cancer Screening Case Studies
Figure 10. Liver Cancer Screening Case Studies
Figure 11. Pancreatic Cancer Screening Case Studies
Figure 12. Skin Cancer Screening Case Studies
Figure 13. Cervical Cancer Screening Case Studies
Figure 14. Other Case Studies
Figure 15. Cancer Screening Technology Report Years Considered
Figure 16. Global Cancer Screening Technology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Cancer Screening Technology Market Share by Regions: 2020 VS 2026
Figure 18. Global Cancer Screening Technology Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Cancer Screening Technology Market Share by Players in 2019
Figure 21. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Screening Technology as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Cancer Screening Technology Revenue in 2019
Figure 23. North America Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Cancer Screening Technology Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Abbott Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 32. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. BD Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 34. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Siemens Healthineers Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 36. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. GE Healthcare Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 38. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. F. Hoffmann-La Roche Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 40. Olympus Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Olympus Corporation Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 42. FUJIFILM Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. FUJIFILM Corporation Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 44. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Agilent Technologies Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 46. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Eiken Chemical Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 48. Hitachi Chemical (Kyowa Medex) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 50. Clinical Genomics Pty Ltd (Quest Diagnostics) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 52. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sysmex Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 54. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. QIAGEN Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 56. R-Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. R-Biopharm Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 58. Immunostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Immunostics Revenue Growth Rate in Cancer Screening Technology Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed